Company Sunflower Pharmaceutical Group Co.,Ltd

Equities

002737

CNE100001WT7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
26.52 CNY +2.31% Intraday chart for Sunflower Pharmaceutical Group Co.,Ltd +1.77% +2.08%

Business Summary

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company provides drugs in six categories, including digestive medicine, pediatric medicine, gynecological medicine, rheumatoid bone medication, breathing cold medication and cardiovascular drugs. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in domestic market.

Number of employees: 5,278

Sales per Business

CNY in Million2022Weight2023Weight Delta
Medicine
164.2 %
8,581 168.4 % 9,361 164.2 % +9.09%
Inter-segment Elimination
-70.7 %
-3,880 -76.2 % -4,030 -70.7 % +3.87%
Other
6.5 %
394 7.7 % 370 6.5 % -6.22%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
5,095 100.0 % 5,700 100.0 % +11.89%

Managers

Managers TitleAgeSince
Chief Executive Officer 42 01-12-31
Director of Finance/CFO 47 -
Chairman 46 -
Chief Administrative Officer 44 -
Director/Board Member 53 -
Director/Board Member 62 11-04-19
Investor Relations Contact - -
Corporate Officer/Principal 61 20-01-02
Corporate Secretary 43 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 64 14-03-25
Director/Board Member 56 22-03-20
Director/Board Member 62 11-04-19
Chief Executive Officer 42 01-12-31
Director/Board Member 73 -
Director/Board Member 61 17-09-25
Director/Board Member 53 -
Chairman 45 19-01-30
Director/Board Member 59 20-10-14
Chief Administrative Officer 44 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 584,000,000 250,293,764 ( 42.86 %) 0 42.86 %

Shareholders

NameEquities%Valuation
265,200,000 49.72 % 1 006 M ¥
35,220,422 6.603 % 134 M ¥
Heilongjiang Jinkui Investment Co. Ltd.
4.500 %
24,000,000 4.500 % 91 M ¥
Basic Pension Insurance Fund 1001 Combination
1.331 %
7,099,944 1.331 % 27 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
1.202 %
6,411,432 1.202 % 24 M ¥
Rongtong Fund Management Co., Ltd.
0.9025 %
4,813,800 0.9025 % 18 M ¥
Caitong Securities Asset Management Co., Ltd.
0.7940 %
4,235,000 0.7940 % 16 M ¥
Sunflower Pharmaceutical Group Co. Ltd. ESOP
0.7837 %
4,180,000 0.7837 % 16 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.6784 %
3,618,418 0.6784 % 14 M ¥
Da Cheng Fund Management Co., Ltd.
0.6691 %
3,568,781 0.6691 % 14 M ¥

Company contact information

Sunflower Pharmaceutical Group Co., Ltd.

No. 18 Donghu Road Jizhong Area, Yingbin Road

150078, Harbin

+

http://www.kuihuayaoye.com
address Sunflower Pharmaceutical Group Co.,Ltd(002737)
  1. Stock Market
  2. Equities
  3. 002737 Stock
  4. Company Sunflower Pharmaceutical Group Co.,Ltd